Evidence map›Paper›PMID 36201111›Full record

ArticleInternational journal of clinical pharmacy2022

Beliefs and attitudes of residents, family members and healthcare professionals regarding deprescribing in long-term care: a qualitative study.

Steven Rowe, Nicole Pittman, Catherine Balsom, Rebecca Druken, Deborah V Kelly

Abstract read
PubMed Publisher
In one paragraph

Article in International journal of clinical pharmacy, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
1.7field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 15 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Observational
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Steven RoweFaculty of Medicine, Newfoundland and Labrador, School of Pharmacy, Memorial University of Newfoundland, Memorial University of Newfoundland, St. John's, Canada.
Nicole PittmanSchool of Pharmacy, Memorial University of Newfoundland, 1 - 75 Tiffany Court, St. John's, A1A 0L1, St. John's, Newfoundland and Labrador, Canada.ORCID http://orcid.org/0000-0003-3041-6704
Catherine BalsomSchool of Pharmacy, Memorial University of Newfoundland, 1 - 75 Tiffany Court, St. John's, A1A 0L1, St. John's, Newfoundland and Labrador, Canada.ORCID http://orcid.org/0000-0002-9003-5869
Rebecca DrukenSchool of Pharmacy, Memorial University of Newfoundland, 1 - 75 Tiffany Court, St. John's, A1A 0L1, St. John's, Newfoundland and Labrador, Canada.
Deborah V KellySchool of Pharmacy, Memorial University of Newfoundland, 1 - 75 Tiffany Court, St. John's, A1A 0L1, St. John's, Newfoundland and Labrador, Canada. dvkelly@mun.ca.ORCID http://orcid.org/0000-0003-3114-8123
Memorial University of Newfoundland · CA

Funding

School of Pharmacy, Memorial University of Newfoundland School of Pharmacy, Memorial University of Newfoundland
6 · The paper itself

Abstract

backgroundPolypharmacy is prevalent among long-term care (LTC) residents and can cause significant morbidity. In 2018, we concluded a deprescribing pilot study that reduced potentially inappropriate medication use among LTC residents.

aimWe sought to understand the experience and views of physicians, nurses, pharmacists, LTC residents and family members who participated in the pilot study.

methodQualitative semi-structured interviews were conducted with residents and families, a physician, pharmacist and pharmacy student, and licensed-practical nurses. Interviews were audio recorded, transcribed, and analyzed using an inductive thematic analysis approach.

resultsInterviews with 13 participants yielded themes in 3 categories: (1) views about medication use in LTC and willingness to engage in deprescribing, (2) perceived barriers and enablers for deprescribing, and (3) impact of participating in deprescribing study. Participants were willing to engage in deprescribing; residents were motivated by physician suggestions, and family members prioritized quality of life in decision-making and wanted to be part of the decision-making process. Solutions to overcome barriers included assigning responsibility to identify deprescribing opportunities to pharmacists, scheduling rounds to enable face-to-face team discussions, and consulting families to provide missing medical history to inform deprescribing decisions. Participating in a deprescribing intervention resulted in improved healthcare professional (HCP) confidence and interprofessional collaboration, and caused continued practice change after the study.

conclusionResidents, families, and HCPs are concerned about problems associated with polypharmacy in LTC and are willing to consider deprescribing. Barriers to deprescribing in LTC exist but are not insurmountable. Results provide valuable insight into strategies to optimize deprescribing interventions within LTC.

Indexed as

DeprescriptionsLong-Term CareAttitude of Health PersonnelFamilyHumansPilot ProjectsPolypharmacyQualitative ResearchQuality of LifeDeprescribingFrail elderlyInterprofessional collaborationLong term carePatientsPharmacist rolePolypharmacy

Identifiers

PMID36201111
OpenAlexW4302293807

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.